Outcomes Following Proton Therapy for Pediatric Low-Grade Glioma

Daniel J. Indelicato1, Ronny L. Rotondo1, Haruka Uezono1, Eric S. Sandler2, Philipp R. Aldana3, Nathan J. Ranalli3, Alexandra D. Beier3, Christopher G. Morris1, Julie A. Bradley1
1Department of Radiation Oncology, University of Florida College of Medicine, Jacksonville, Florida
2Nemours Children's Health System, Jacksonville, Florida
3Department of Neurosurgery, University of Florida College of Medicine, Jacksonville, Florida

Tài liệu tham khảo

Williams, 2018, Late Effects After Radiotherapy for Childhood Low-grade Glioma, American journal of clinical oncology, 41, 307, 10.1097/COC.0000000000000267 Merchant, 2009, Phase II trial of conformal radiation therapy for pediatric low-grade glioma, J Clin Oncol, 27, 3598, 10.1200/JCO.2008.20.9494 Marcus, 2005, Stereotactic radiotherapy for localized low-grade gliomas in children: Final results of a prospective trial, Int J Radiat Oncol Biol Phys, 61, 374, 10.1016/j.ijrobp.2004.06.012 Greenberger, 2014, Clinical outcomes and late endocrine, neurocognitive, and visual profiles of proton radiation for pediatric low-grade gliomas, Int J Radiat Oncol Biol Phys, 89, 1060, 10.1016/j.ijrobp.2014.04.053 Eaton, 2014, The use of proton therapy in the treatment of benign or low-grade pediatric brain tumors, Cancer J, 20, 403, 10.1097/PPO.0000000000000079 Amelio, 2013, Intensity modulated radiation therapy (IMRT) versus intensity modulated proton therapy (IMPT) in low-grade gliomas: A dosimetric study, Int J Radiat Oncol Biol Phys, 87, S253, 10.1016/j.ijrobp.2013.06.658 Journy N, Indelicato DJ, Withrow DR, et al. Patterns of proton therapy use in pediatric cancer management in 2016: An international survey. Paper presented at: Conference on Radiation & Health 2018. September 23-25, 2018; Chicago, IL. Indelicato, 2017, Clinical outcomes following proton therapy for children with central nervous system tumors referred overseas, Pediatr Blood Cancer, 64, 10.1002/pbc.26654 Hug, 2002, Conformal proton radiation therapy for pediatric low-grade astrocytomas, Strahlenther Onkol, 178, 10, 10.1007/s00066-002-0874-2 Mannina, 2016, Extended volumetric follow-up of juvenile pilocytic astrocytomas treated with proton beam therapy, Int J Part Ther, 3, 291, 10.14338/IJPT-16-00020.1 Cherlow, 2019, Conformal radiation therapy for pediatric patients with low-grade glioma: Results from the Children’s Oncology Group Phase 2 Study ACNS0221, Int J Radiat Oncol Biol Phys, 103, 861, 10.1016/j.ijrobp.2018.11.004 Chong, 2013, Optic pathway gliomas in adolescence—Time to challenge treatment choices?, Neuro Oncol, 15, 391, 10.1093/neuonc/nos312 Packer, 2010, Radiation therapy for pediatric low-grade gliomas: Survival and sequelae, Curr Neurol Neurosci Rep, 10, 10, 10.1007/s11910-009-0084-8 Mishra, 2006, The role of up-front radiation therapy for incompletely resected pediatric WHO grade II low-grade gliomas, Neuro Oncol, 8, 166, 10.1215/15228517-2005-011 Gnekow, 2012, Long-term follow-up of the multicenter, multidisciplinary treatment study HIT-LGG-1996 for low-grade glioma in children and adolescents of the German Speaking Society of Pediatric Oncology and Hematology, Neuro Oncol, 14, 1265, 10.1093/neuonc/nos202 Tsang, 2017, Radiation therapy for optic pathway and hypothalamic low-grade gliomas in children, Int J Radiat Oncol Biol Phys, 99, 642, 10.1016/j.ijrobp.2017.07.023 Mansur, 2011, Radiation therapy for pilocytic astrocytomas of childhood, Int J Radiat Oncol Biol Phys, 79, 829, 10.1016/j.ijrobp.2009.11.015 Brown, 2013, Proton beam craniospinal irradiation reduces acute toxicity for adults with medulloblastoma, Int J Radiat Oncol Biol Phys, 86, 277, 10.1016/j.ijrobp.2013.01.014 Wan, 2016, Long-term visual outcomes of optic pathway gliomas in pediatric patients without neurofibromatosis type 1, J Neurooncol, 129, 173, 10.1007/s11060-016-2163-4 Awdeh, 2012, Visual outcomes in pediatric optic pathway glioma after conformal radiation therapy, Int J Radiat Oncol Biol Phys, 84, 46, 10.1016/j.ijrobp.2011.10.067 Huynh-Le, 2016, Management of pediatric intracranial low-grade gliomas: Long-term follow-up after radiation therapy, Childs Nerv Syst, 32, 1425, 10.1007/s00381-016-3100-8 Hall, 2018, Risk of radiation vasculopathy and stroke in pediatric patients treated with proton therapy for brain and skull base tumors, Int J Radiat Oncol Biol Phys, 101, 854, 10.1016/j.ijrobp.2018.03.027 Haas-Kogan, 2018, National Cancer Institute Workshop on Proton Therapy for Children: Considerations regarding brainstem injury, Int J Radiat Oncol Biol Phys, 101, 152, 10.1016/j.ijrobp.2018.01.013 Plimpton, 2015, Cerebral radiation necrosis in pediatric patients, Pediatr Hematol Oncol, 32, 78, 10.3109/08880018.2013.791738 Lassen-Ramshad, 2015, Pseudoprogression after proton radiotherapy for pediatric low grade glioma, Acta Oncol, 54, 1701, 10.3109/0284186X.2015.1078498 Tsang, 2017, Pseudoprogression in pediatric low-grade glioma after irradiation, J Neurooncol, 135, 371, 10.1007/s11060-017-2583-9 Karim, 1996, A randomized trial on dose-response in radiation therapy of low-grade cerebral glioma: European Organization for Research and Treatment of Cancer (EORTC) Study 22844, Int J Radiat Oncol Biol Phys, 36, 549, 10.1016/S0360-3016(96)00352-5 Perilongo, 2005, Considerations on the role of chemotherapy and modern radiotherapy in the treatment of childhood low grade glioma, J Neurooncol, 75, 301, 10.1007/s11060-005-6754-8 Cappellano, 2015, Single agent vinorelbine in pediatric patients with progressive optic pathway glioma, J Neurooncol, 121, 405, 10.1007/s11060-014-1652-6 Packer, 1993, Carboplatin and vincristine for recurrent and newly diagnosed low-grade gliomas of childhood, J Clin Oncol, 11, 850, 10.1200/JCO.1993.11.5.850 Gnekow, 2017, A European randomised controlled trial of the addition of etoposide to standard vincristine and carboplatin induction as part of an 18-month treatment programme for childhood (≤16 years) low grade glioma —A final report, Eur J Cancer, 81, 206, 10.1016/j.ejca.2017.04.019 Lassaletta, 2017, Therapeutic and prognostic implications of BRAF V600E in pediatric low-grade gliomas, J Clin Oncol, 35, 2934, 10.1200/JCO.2016.71.8726